- All site RSS

News

Skolkovo First in Line at Customs Service
The Federal Customs Service published a draft order on Thursday that would give Skolkovo preferential customs treatment for all of the goods it imports from abroad. The head of Skolkovo's legal department...

Regenerative Medicine Day at Skolkovo. February 14, 2013 declared as a “Regenerative medicine day in Russia” by Skolkovo Innovative Centre.
Conference devoted to a cross-disciplinary (biology, medicine, physics, chemistry) science - regenerative medicine – was sponsored by the Russian company 3D bioprinting solutions (executive director Aleksandr...

CONRTACTED STUDIES
Institute for Atherosclerosis Research offers the service on organization and conducting of cross-sectional clinical trials in representative samples of 150-300 study participants in the field of novel...

Russia’s Most Innovative Companies Invited to Compete in the Country’s Second Annual Best Innovator Competition
The Best Innovator competition launched in Russia for the second year in a row. The Skolkovo Institute of Science and Technology (Skoltech) will co-sponsor the event hosted by global management consulting...

Skoltech Moves Forward With E-Infrastructure
The Skolkovo Institute of Science and Technology (Skoltech) and the National Association of Research and Educational e-Infrastructures (e-ARENA) announced the first steps in their partnership to improve...

Accenture Links with Skolkovo for Russian Analytics Hub
Global consultancy Accenture and Moscow-based non-profit organization the Skolkovo Foundation have partnered to establish a centre through which to develop and commercialize new predictive analytics technologies...

Skolkovo is believed to be Russia's 'Innovation City".
Four years ago, the government allocated over 2 billion euros to develop a STEM (Science, Technology, Engineering and Maths) hub for students. One of the key goals is to connect science and business, so...

Success Stories: June, 2013
"TheraMAB" announced the receipt of the second tranche of venture capital investment in the amount of 157 million rubles. The company "Spektralazer" was certified according to Quality...

CardioNova recruits first patient in Phase I/IIa clinical trial of AHRO-001 aimed at treatment of dyslipidemia and prevention of atherosclerosis
Skolkovo Biomedical Cluster Resident "CardioNova", founded with investments from Maxwell Biotech Venture Fund founded with the participation of RVC, announced today enrollment of the first volunteers...